Lind Global Fund III LP Sample Contracts
JOINT FILING AGREEMENTJoint Filing Agreement • August 5th, 2026 • Lind Global Fund III LP • Electromedical & electrotherapeutic apparatus
Contract Type FiledAugust 5th, 2026 Company IndustryThe undersigned hereby agree that a single Schedule 13G (or any amendment thereto) relating to the Common Stock, par value $0.0001 per share, of Nuwellis, Inc. shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13G.
JOINT FILING AGREEMENTJoint Filing Agreement • August 5th, 2026 • Lind Global Fund III LP • Pharmaceutical preparations
Contract Type FiledAugust 5th, 2026 Company IndustryThe undersigned hereby agree that a single Schedule 13G (or any amendment thereto) relating to the Common Stock, par value $0.0001 per share, of 60 Degrees Pharmaceuticals, Inc. shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13G.
JOINT FILING AGREEMENTJoint Filing Agreement • March 20th, 2026 • Lind Global Fund III LP • Beverages
Contract Type FiledMarch 20th, 2026 Company IndustryThe undersigned hereby agree that a single Schedule 13G (or any amendment thereto) relating to the Ordinary Shares, no par value per share, of Innovation Beverage Group Ltd shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13G.
JOINT FILING AGREEMENTJoint Filing Agreement • July 15th, 2026 • Lind Global Fund III LP • Services-prepackaged software
Contract Type FiledJuly 15th, 2026 Company IndustryThe undersigned hereby agree that a single Schedule 13G (or any amendment thereto) relating to the Common Shares of DEFSEC Technologies Inc. shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13G.
JOINT FILING AGREEMENTJoint Filing Agreement • July 31st, 2026 • Lind Global Fund III LP • Deep sea foreign transportation of freight
Contract Type FiledJuly 31st, 2026 Company IndustryThe undersigned hereby agree that a single Schedule 13G (or any amendment thereto) relating to the Common Shares of C3is Inc. shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13G.
JOINT FILING AGREEMENTJoint Filing Agreement • February 19th, 2026 • Lind Global Fund III LP • Services-prepackaged software
Contract Type FiledFebruary 19th, 2026 Company IndustryThe undersigned hereby agree that a single Schedule 13G (or any amendment thereto) relating to the Common Stock, par value $0.00001 per share, of Iveda Solutions, Inc. shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13G.
JOINT FILING AGREEMENTJoint Filing Agreement • August 28th, 2026 • Lind Global Fund III LP • Pharmaceutical preparations
Contract Type FiledAugust 28th, 2026 Company IndustryThe undersigned hereby agree that a single Schedule 13G (or any amendment thereto) relating to the Common Stock, $0.0001 par value, of Daré Bioscience, Inc. shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13G.
JOINT FILING AGREEMENTJoint Filing Agreement • September 18th, 2025 • Lind Global Fund III LP • Biological products, (no disgnostic substances)
Contract Type FiledSeptember 18th, 2025 Company IndustryThe undersigned hereby agree that a single Schedule 13G (or any amendment thereto) relating to the Ordinary shares, par value $0.0135 per share, of Silexion Therapeutics Corp shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13G.
JOINT FILING AGREEMENTJoint Filing Agreement • September 24th, 2025 • Lind Global Fund III LP • Laboratory analytical instruments
Contract Type FiledSeptember 24th, 2025 Company IndustryThe undersigned hereby agree that a single Schedule 13G (or any amendment thereto) relating to the Common Stock, par value $0.0001 per share, of Bionano Genomics, Inc. shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13G.
JOINT FILING AGREEMENTJoint Filing Agreement • February 4th, 2026 • Lind Global Fund III LP • Pharmaceutical preparations
Contract Type FiledFebruary 4th, 2026 Company IndustryThe undersigned hereby agree that a single Schedule 13G (or any amendment thereto) relating to the Common Stock, $0.01 par value, of Enveric Biosciences, Inc. shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13G.
JOINT FILING AGREEMENTJoint Filing Agreement • December 23rd, 2025 • Lind Global Fund III LP • Services-prepackaged software
Contract Type FiledDecember 23rd, 2025 Company IndustryThe undersigned hereby agree that a single Schedule 13G (or any amendment thereto) relating to the Common Shares, no par value, of DEFSEC Technologies Inc. shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13G.
